Dave Dullum
Analyst · Jefferies. Please proceed
Hey, Mike. Thanks much and good morning, likewise to everybody. Certainly, I am happy today to report that we have come through the fiscal year 3/31/21, with a minimum of COVID scars. We did end the year with an adjusted NII of $0.69 per share with the last two quarters really importantly showing a recovery trend with the adjusted NII per share at $0.20 and $0.24, respectively. I wanted to say that this trend really an income level reflects the COVID impact on the first two quarters, where we did limit the other income from portfolio companies and obviously where we reduced some interest income as well. Along the lines, we also increased NAV per share from $11.17 to 3/31/20 to $11.52 per share at 3/31/21 and we are able to increase assets to $644 million from $576 million. We maintained our monthly distribution at $0.07 per share, or $0.84 per share on an annual basis and also paid a supplemental dividend of $0.09 per share in June of 2020. We were able to exit one portfolio company, completed a dividend recapitalization of another, both of which generated other income, which was from exit fees and/or dividends and we also had realized capital gains on equity. We made one new buyout investment and then also incremental investments on some existing portfolio companies and in one case help facilitate actually an accretive add-on acquisition. That dimension here though that since inception in 2005 and through 3/31/21, we have invested in 53 buyout portfolio companies, with an aggregate of about $1.4 billion. We exited 23 of these companies generating about $238 million in net realized gains and over $31 million in other income on exit. I mentioned this, as it really reinforces our buyout in investing strategy to generate both income from monthly distributions to shareholders and capital gains on equity for supplemental distributions. This provides some stability, especially in periods as we have recently experienced. It is also important to note the effect of the quarterly changes in our portfolio company’s equity values as they are at a very high correlation to the overall portfolio value, given that about 25% of our assets at cost of equity securities, and again, this is a somewhat of a differentiator to other policies. So, where we experienced primarily equity valuation declines early in the COVID cycle, we are seeing clearly improving valuations and therefore increases quarter-over-quarter. Two other areas I would like to briefly touch on is one, we are seeing two of our portfolio companies that were on non-accrual come back on accrual status this quarter and hope to continue that trend during the next fiscal year with at least two other companies. And given the exits and the favorable financings that we were able to execute before 3/31/21, we begin the new fiscal year with a very strong and low levered balance sheet and excellent liquidity availability, and Julia actually will elaborate more on this in her section. Regarding pandemic, I briefly want to review with the portfolio companies that we did have that experienced any disruption in earnings decline are starting to see some real improvement. And fortunately, we did not have to provide much financial support although we do continue to actively monitor potential issues and are proactively engaged with our company’s management teams to provide support as necessary. And as I mentioned, we are in a strong liquidity position and able to provide support to any of our companies really to face temporary liquidity needs. So looking forward, we just continue to provide managerial financial support to our portfolio companies while we continue to actively review potential new acquisitions. And the buyout market though does continue to present challenges with purchase price expectations being elevated. So, we have to maintain our discipline as usual and a high level of due diligence, although we currently are engaging in discussions with a few acquisition opportunities where I do believe we might be in a position to take advantage of attractive valuations and closed some deals. Overall, I am encouraged by the state of our portfolio, the strength of our balance sheet, and the prospect of good earnings and distributions over the next year. I want to just elaborate that the structure of our portfolio is geared to providing consistent monthly distributions with a view to increasing as appropriate. And in that respect, we expect to continue our run rate monthly distribution of $0.84 per share annually and we have declared another supplemental distribution of $0.06 per share to be paid in June of 2021. So with that, I will turn it over to Julia and she can go with some more details. Julia?